Skip to main content
. 2022 Jun 15;9(5):2909–2917. doi: 10.1002/ehf2.13982

Figure 3.

Figure 3

The distribution of patients with left ventricular reverse remodelling (responder) in relation to Sac/Val dosage reached after 6 months (P = 0.053).